Dr Robert H Eckel, MD

Dr Robert H Eckel

Disclosure details

Amgen, Arrowhead (DSMB), 89bio, Ionis, Madrigal, New Amsterdam, Novo Nordisk, Precision BioSciences, Regeneron (expert witness), The Healthy Aging Co., Tolmar, UpToDate

Professor of Medicine, Emeritus, Division of Endocrinology, Metabolism, and Diabetes, Division of Cardiology, Department of Physiology and Biophysics , University of Colorado Anschutz Medical Center, Aurora, CO, USA

Robert H Eckel, MD, is the former Charles A. Boettcher Endowed Chair in Atherosclerosis in the Department of Medicine at the University of Colorado Anschutz Medical Campus (UCAMC) in Aurora, CO.   Dr Eckel is a distinguished alumnus of the University of Cincinnati College of Medicine in Cincinnati, OH. He performed a Medical Residency at the University of Wisconsin Hospitals in Madison, WI, and a Senior Fellowship in Metabolism and Endocrinology at the University of Washington School of Medicine in Seattle, WA.

For nearly 30 years Dr Eckel served as the associate and then program director of the Adult General Clinical Research Center, and subsequently as the interim vice chancellor for research.  Dr Eckel is past president of the American Heart Association; American Diabetes Association (Medicine and Science); the Obesity Society, and the Association of Patient-Oriented Research.  He was a former member of the Extramural Advisory Council of NIDDK, been a contributor to various professional guidelines, and has received numerous awards.

Dr Eckel has published over 400 articles/editorials in peer-reviewed journals and his translational research has used populations, human subjects, genetically modified mice, and molecular techniques to pursue physiologic and pathophysiological insights into cardiometabolic disorders such as obesity, metabolic syndrome, diabetes, cardiovascular disease, and more recently neurodegenerative diseases.